Article - 21/05/2013 Green gold: bioactive plant foods Nowadays everything must be good for something must have a direct noticeable or tangible effect. The ever topical issue of nutrition is no exception. All this makes functional food a promising and inexhaustible market. Teams of scientists around the world are focussing on how unhealthy food can be made healthy. Bioactive plant foods are expected to close a gap that should not have existed in the first place. https://www.gesundheitsindustrie-bw.de/en/article/news/green-gold-bioactive-plant-foods
Dossier - 13/05/2013 The human proteome – the next major goal The “Human Proteome Project”, a ten-year global initiative that is making a systematic effort to map all human proteins, has moved from the planning to the experimental stage. How significant and how effective the project will be depends on how much the resources offered are used by proteome researchers and on the data that the researchers bring into the project. https://www.gesundheitsindustrie-bw.de/en/article/dossier/the-human-proteome-the-next-major-goal
Article - 08/04/2013 Top position for German placebo research Placebo research at Tübingen University is part of a German network that is a world leader in the field. One of the research priorities relates to the perception of pain and the underlying neurobiological mechanisms. https://www.gesundheitsindustrie-bw.de/en/article/news/top-position-for-german-placebo-research
Article - 18/03/2013 Protein depositions in the brain promote the development of amyotrophic lateral sclerosis (ALS) Being aware of ones own physical degradation as intellect and cognition remain completely intact this is what the disease amyotrophic lateral sclerosis ALS also known as Lou Gehrigs disease means to sufferers. The disease is currently not curable as far too little is known as yet about its causes. However basic research is making progress and providing increasing insights into the causes of ALS. Dr. Günter Fritz and his colleagues from the…https://www.gesundheitsindustrie-bw.de/en/article/news/protein-depositions-in-the-brain-promote-the-development-of-amyotrophic-lateral-sclerosis-als
Article - 12/03/2013 Science to business – exit strategies for biotech companies The two directors of the consultancy firm LSCN Ltd. Dr. Alrik Koppenhöfer and Dr. Volker Ungermann explain the key issues involved in MA negotiations and licensing deals and how LSCN supports biotechnology companies and strategic investors in reaching their goals. Both managers agree that a good dose of realism is necessary. https://www.gesundheitsindustrie-bw.de/en/article/news/science-to-business-exit-strategies-for-biotech-companies
Article - 04/03/2013 Genomic structural variations can cause cancer Genome-wide sequencing analyses show that comprehensive structural variations of chromosomes can play a key role in the pathogenesis of many types of cancer. Dr. Jan Korbel’s research group at the European Molecular Biology Laboratory in Heidelberg has been investigating chromosomal aberrations in paediatric brain tumours and early-onset prostate cancer.https://www.gesundheitsindustrie-bw.de/en/article/news/genomic-structural-variations-can-cause-cancer
Article - 25/02/2013 How can light be used to control the behaviour of neurons? The control of the behaviour of individual neurons simply by switching light stimuli on and off sends neuroscientists into raptures as it reveals insights into as yet hidden and complicated processes in the brain. Thanks to optogenetics this particular science fiction became reality a few years ago. Working with researchers from the Bernstein Center at the University of Freiburg and the Friedrich Miescher Institute for Biomedical Research in…https://www.gesundheitsindustrie-bw.de/en/article/news/how-can-light-be-used-to-control-the-behaviour-of-neurons
Article - 18/02/2013 Biotechnology in Biberach: a success story that breaks new ground At its New Year reception Biberach University of Applied Sciences outlined the universitys success the establishment of its biotechnology programme is going smoothly and student interest remains steady. Biberach also has a successful track record of acquiring third-party funding and has established new national and international cooperations.https://www.gesundheitsindustrie-bw.de/en/article/news/biotechnology-in-biberach-a-success-story-that-breaks-new-ground
Article - 18/02/2013 Dickkopf deficiency improves cognitive performance Scientists from the German Cancer Research Center have shown that the Dickkopf gene, which regulates head development during embryogenesis, prevents the regeneration of nerve cells in the mouse hippocampus. This also leads to the loss of learning capacity in advanced age. Animals in advanced adult age whose Dickkopf gene had been silenced showed no age-related decline in cognitive performance.https://www.gesundheitsindustrie-bw.de/en/article/news/dickkopf-deficiency-improves-cognitive-performance
Article - 11/02/2013 The Human Brain Project The Human Brain Project has been granted funding under the EU’s multi-billion euro competition, Future and Emerging Technolgies (FET). The project will receive funds of over one billion euros for a period of ten years and endeavour to simulate the human brain using newly developed supercomputers. https://www.gesundheitsindustrie-bw.de/en/article/news/the-human-brain-project
Article - 04/02/2013 SYGNIS Pharma - the "new" one: development and commercialisation of molecular diagnostics products Heidelberg-based SYGNIS Pharma AG is to discontinue its therapeutic R&D projects targeting human nervous system diseases and will in future focus on the research and development of novel molecular biology technologies, including DNA amplification and sequencing as well as drug screening.https://www.gesundheitsindustrie-bw.de/en/article/news/sygnis-pharma-the-new-one-development-and-commercialisation-of-molecular-diagnostics-products
Article - 28/01/2013 Dietmar Thal and the Alzheimer ABC The initial consensus guidelines for the postmortem diagnosis of Alzheimer’s disease were published in 1997. In the same year, Dietmar Thal started his four-year research project at the Institute of Anatomy at the University of Frankfurt under the supervision of Heiko Braak, who was then one of the leading figures in Alzheimer’s research, notably for his achievements in grading the presence and distribution of tau tangles in the brain in 1991. In…https://www.gesundheitsindustrie-bw.de/en/article/news/dietmar-thal-and-the-alzheimer-abc
Article - 31/12/2012 Niels Birbaumer - psychologist for the brain Niels Birbaumer is one of the leading figures in the history of brain-computer interfaces (BCI), which are direct communication devices between the brain and a computer. Birbaumer has been dealing with BCIs for as much as forty years. He believes in the power of BCIs, a power that is based on human imagination and is used to treat brain disturbances. The director of the Institute of Medical Psychology and Behavioural Neurology in Tübingen was…https://www.gesundheitsindustrie-bw.de/en/article/news/niels-birbaumer-psychologist-for-the-brain
Article - 19/12/2012 Interpretation affects visual perception Dr. Hendrikje Nienborg is investigating how visual information is processed in the brain. Her most important finding is that the way we interpret visual information influences visual processing and perception. The neuroscientist uses awake mammals to investigate the mechanisms in the visual cortex that underlie visual perception. Dr. Nienborg was awarded an ERC Starting Grant worth 1.9 million euros for her research into the neural foundations of…https://www.gesundheitsindustrie-bw.de/en/article/news/interpretation-affects-visual-perception
Press release - 29/11/2012 Neural interaction in periods of silence While in deep dreamless sleep our hippocampus sends messages to our cortex and changes its plasticity possibly transferring recently acquired knowledge to long-term memory. But how exactly is this done? Scientists from the Max Planck Institute for Biological Cybernetics have now developed a novel multimodal methodology called neural event-triggered functional magnetic resonance imaging NET-fMRI and presented the very first results obtained using…https://www.gesundheitsindustrie-bw.de/en/article/press-release/neural-interaction-in-periods-of-silence
Press release - 26/11/2012 Functional Magnetic Resonance Imaging under the Magnifying Glass Jozien Goense from the Max Planck Institute for Biological Cybernetics in Tübingen Germany and her colleagues used functional Magnetic Resonance Imaging fMRI to observe these layer-specific neural processes within the cortex and found different mechanisms for fMRI response increases and decreases as well as cortical layer-dependent differences in the neurovascular coupling mechanism. https://www.gesundheitsindustrie-bw.de/en/article/press-release/functional-magnetic-resonance-imaging-under-the-magnifying-glass
Article - 12/11/2012 Otmar D. Wiestler – combining excellent research and cancer medicine The University of Tübingen Medical Faculty’s award of an honorary doctorate to the Chairman of the Executive Board of the German Cancer Research Center, Professor Dr. Otmar D. Wiestler, was not just a distinction awarded to a renowned neuropathologist, oncologist and stem cell researcher, it also honoured a well-known personality who has made a significant contribution to shaping health research in Germany.https://www.gesundheitsindustrie-bw.de/en/article/news/otmar-d-wiestler-combining-excellent-research-and-cancer-medicine
Press release - 09/11/2012 Apogenix’s Apocept™ for glioblastoma multiforme named one of “Top 10 Projects to Watch” Apogenix a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases announced that its lead product Apocept APG101 has been selected by Elsevier Business Intelligence and Windhover Conferences as one of oncologys Top 10 Projects To Watch.https://www.gesundheitsindustrie-bw.de/en/article/press-release/apogenix-s-apocept-for-glioblastoma-multiforme-named-one-of-top-10-projects-to-watch
Dossier - 05/11/2012 Cancer – basic research, successes and trends Science is approaching cancer treatment by using new systems biology approaches and setting up large-scale multidisciplinary projects such as the International Cancer Genome Consortium. Progress in genome, epigenome and gene expression analyses of cancer cells, new insights into the regulation and interaction of cells gained in cooperation with stem cell research and virus research contributes to gaining a causal understanding of cancer. This…https://www.gesundheitsindustrie-bw.de/en/article/dossier/cancer-basic-research-successes-and-trends
Article - 29/10/2012 Friederike J. Gruhl – biology is not always enough Researchers are usually only able to explore the development and growth of tumours with animal models. This is because many human cells lose their typical characteristics once outside the body. Friederike J. Gruhl from the Karlsruhe Institute of Technology KIT is working to create a biomimetic environment in Petri dishes in which prostate cells thrive and can be manipulated to become tumours for example - if required. The three-dimensional…https://www.gesundheitsindustrie-bw.de/en/article/news/friederike-j-gruhl-biology-is-not-always-enough
Article - 22/10/2012 syneed imaging: precise visualisation of functional tissue properties Functional medical imaging modalities are of great significance in modern medical diagnostics. Existing ways of diagnosing diseases are now being expanded with the arrival of the innovative parameter imaging method. syneed imaging uses proprietary highly sensitive software for the analysis of dynamic image data. This software complements standard methods such as computed tomography and magnetic resonance imaging and increases the significance of…https://www.gesundheitsindustrie-bw.de/en/article/news/syneed-imaging-precise-visualisation-of-functional-tissue-properties
Article - 15/10/2012 Carmen Ruiz de Almodóvar and the link between the nervous and vascular systems Dr. Carmen Ruiz de Almodóvar from the Heidelberg University Biochemistry Centre has been awarded an ERC Starting Grant to study the molecular similarities between the nervous and vascular systems. The researcher showed that angiogenic factors such as VEGF also control the growth of neuronal cells and may be responsible for disorders in the development of nervous systems.https://www.gesundheitsindustrie-bw.de/en/article/news/carmen-ruiz-de-almod-var-and-the-link-between-the-nervous-and-vascular-systems
Article - 08/10/2012 Epilepsy changes brain architecture Epileptic fits, i. e. abnormal excessive neuronal activity in the hippocampus, severely affects nerve cells and can lead to permanent damage. A team of researchers led by Prof. Dr. Carola Haas from the Neurocenter at the University of Freiburg is focusing on changes in the brain anatomy of patients suffering from temporal lobe epilepsy as well as on the molecular and cellular processes underlying the disease. The team’s research focuses on stem…https://www.gesundheitsindustrie-bw.de/en/article/news/epilepsy-changes-brain-architecture
Press release - 02/10/2012 Scientists find explanation for formation of connections between nerve cells Multiple synaptic contacts between nerve cells facilitate the creation of a new contact as neuroscientists from the Bernstein Center Freiburg and the Forschungszentrum Jülich report in the latest issue of the journal PLoS Computational Biology. An integral mechanism of memory foundation is the formation of additional contacts between neurons in the brain.https://www.gesundheitsindustrie-bw.de/en/article/press-release/scientists-find-explanation-for-formation-of-connections-between-nerve-cells
Article - 10/09/2012 "BrainLinks-BrainTools" – how an intention becomes reality An accident victim is no longer able to pick up a tea cup because the nerves between the brain and the arm are severed. Researchers from the faculties of biology medicine and technology at the University of Freiburg are able to translate pure thought into the movement of a cursor on a computer screen. The researchers are part of the BrainLinks-BrainTools consortium.https://www.gesundheitsindustrie-bw.de/en/article/news/brainlinks-braintools-how-an-intention-becomes-reality